Business Standard

Wednesday, December 25, 2024 | 10:13 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

With 350% stock gain, drugmaker Laurus Labs seeks to boost capacity

The pharmaceutical sector is the top performer in India's $2.1 trillion equity market this year after the coronavirus pandemic turned global investors' spotlight on health-care companies

Satyanarayana Chava, Founder, Laurus Labs
Premium

Satyanarayana Chava, Founder, Laurus Labs

Nupur Acharya and Ronojoy Mazumdar | Bloomberg
Indian pharmaceutical company Laurus Labs Ltd. plans to spend as much as 15 billion rupees ($202 million) over the next 24 months to expand its production capacity, according to its chief executive officer.

“We have a good visibility of orders going forward and this large capital outlay will help us meet the needs of the customers,” Satyanarayana Chava, also the company’s founder, said in a phone interview Thursday after it reported second-quarter profit that rose more than fourfold from a year earlier to 2.43 billion rupees.

The pharmaceutical sector is the top performer in India’s $2.1 trillion equity market this year after

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in